California News Observer
SEE OTHER BRANDS

The most trusted news from California

California News Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California News Observer.

Press releases published on July 11, 2025

DEADLINE ALERT for RDDT, HIMS, IRBT, and CNC: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

DEADLINE ALERT for RDDT, HIMS, IRBT, and CNC: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

LOS ANGELES, July 11, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed …

Create Source Media releases 'Confío Celebro,' a global inspirational Spanish song / canción inspiradora

Create Source Media releases 'Confío Celebro,' a global inspirational Spanish song / canción inspiradora

“Create Source Media amplifies hope worldwide with powerful new inspirational Global Spanish anthem” LOS ANGELAS, CA, UNITED STATES, July 10, 2025 /⁨EINPresswire.com⁩/ -- Create Source Media announces “Confío Celebro,” releasing August 8, 2025 via The …

 Music, Memories and Miracles: 28th Annual Stars and Stripes Raises $6M for Kids’ Charities

Music, Memories and Miracles: 28th Annual Stars and Stripes Raises $6M for Kids’ Charities

OneRepublic, Little Big Town …

CAI Community Launches AlgoFusion 5.0 Led by Alaric Bennett

CAI Community Launches AlgoFusion 5.0 Led by Alaric Bennett

Los Angeles, CA, July 11, 2025 (GLOBE NEWSWIRE) -- CAI Community, the investor-focused learning platform established by hedge fund veteran Alaric Bennett, has officially announced the release of AlgoFusion 5.0, a major update to its proprietary trading …

Neurona Announces Publication in Neuron Reporting Durable Preclinical Engraftment of Human Interneuron Cell Therapy

Neurona Announces Publication in Neuron Reporting Durable Preclinical Engraftment of Human Interneuron Cell Therapy

SAN FRANCISCO, July 11, 2025 (GLOBE NEWSWIRE) -- Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for disorders of the nervous system, today published a new peer-reviewed study in Neuron, a Cell Press …

Johnson Fistel Begins Investigation on Behalf of RxSight, Inc. (RXST) Shareholders

Johnson Fistel Begins Investigation on Behalf of RxSight, Inc. (RXST) Shareholders

SAN DIEGO, July 11, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP is investigating whether RxSight, Inc. (NASDAQ: RXST), or any of its executive officers, violated federal securities laws by making false or misleading statements …

Immix Biopharma Announces Class-Leading Safety Profile, Allowing Potential Future Indication Expansion

Immix Biopharma Announces Class-Leading Safety Profile, Allowing Potential Future Indication Expansion

– Absence of neurotoxicity of any grade in low-volume disease to-date – – On track for first Biologics License Application (BLA) approved cell therapy in orphan indication relapsed/refractory AL Amyloidosis – – Potential future indication expansion planned …

XPLR INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that XPLR Infrastructure, LP f/k/a NextEra Energy Partners, LP Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – XIFR

XPLR INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that XPLR Infrastructure, LP f/k/a NextEra Energy Partners, LP Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – XIFR

SAN DIEGO, July 11, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman …

INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Centene Corporation (CNC) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Centene Corporation (CNC) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

SAN DIEGO, July 11, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman …

Johnson Fistel Begins Investigation on Behalf of BellRing Brands, Inc. (BRBR) Shareholders

Johnson Fistel Begins Investigation on Behalf of BellRing Brands, Inc. (BRBR) Shareholders

SAN DIEGO, July 11, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP, is investigating whether BellRing Brands, Inc. (NYSE: BRBR), or any of its executive officers, violated securities laws by misrepresenting or failing to timely …

Johnson Fistel Begins Investigation on Behalf of KinderCare Learning Companies, Inc. (KLC) Shareholders

Johnson Fistel Begins Investigation on Behalf of KinderCare Learning Companies, Inc. (KLC) Shareholders

SAN DIEGO, July 11, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP is investigating whether KinderCare Learning Companies, Inc. (NYSE: KLC), or any of its executive officers, violated securities laws by misrepresenting or failing …

ServiceTitan to Host Investor Session at Pantheon 2025

ServiceTitan to Host Investor Session at Pantheon 2025

LOS ANGELES, July 11, 2025 (GLOBE NEWSWIRE) -- ServiceTitan (Nasdaq: TTAN), the software platform that powers the trades, today announced that it will host an investor session at Pantheon 2025, the Company’s annual user conference in Anaheim, CA. The in- …

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., July 11, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and …

Crinetics Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 7, 2025

Crinetics Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 7, 2025

SAN DIEGO, July 11, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report second quarter 2025 financial results on Thursday, August 7, 2025 after the market closes. Company management will host a …

Daré Bioscience Receives $6 Million Non-Dilutive Grant Installment; $37.8M to Date of up to $49M Commitment Supporting Smart Drug Delivery Device for Contraception; Platform has Broader Application Potential in Obesity and Metabolic Disorders

Daré Bioscience Receives $6 Million Non-Dilutive Grant Installment; $37.8M to Date of up to $49M Commitment Supporting Smart Drug Delivery Device for Contraception; Platform has Broader Application Potential in Obesity and Metabolic Disorders

SAN DIEGO, July 11, 2025 (GLOBE NEWSWIRE) --  Daré Bioscience, Inc. (NASDAQ: DARE), a biopharmaceutical company driven by a mission to challenge the status quo, making women's health a priority, today announced the receipt of a $6 million non-dilutive …

Heartflow Plaque Analysis Awarded First Coverage Recommendation by Radiology Benefits Manager

Heartflow Plaque Analysis Awarded First Coverage Recommendation by Radiology Benefits Manager

MOUNTAIN VIEW, Calif., July 11, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc., the leader in AI technology for coronary artery disease (CAD), today announced Heartflow Plaque Analysis will be included in updated cardiac imaging guidelines by radiology benefit …

Ugh, As If! The Bratz Betties Just Went Full-On Clueless in This Totally Major Collector Collab

Ugh, As If! The Bratz Betties Just Went Full-On Clueless in This Totally Major Collector Collab

LOS ANGELES, July 11, 2025 (GLOBE NEWSWIRE) -- Bratz®, the on-trend lifestyle and fashion doll brand from MGA Entertainment (MGA), announced today the launch of its Bratz x Clueless Collector dolls in collaboration with Paramount Consumer Products, a …

Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA for Duchenne Muscular Dystrophy

Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA for Duchenne Muscular Dystrophy

FDA issued Complete Response Letter Capricor plans to resubmit its BLA to include data from the ongoing Phase 3 HOPE-3 trial in Q3 2025 to continue pursuing the indication for the treatment of cardiomyopathy associated with Duchenne muscular dystrophy FDA …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service